Optum guides members and providers through important upcoming formulary updates. See multiple tabs of linked spreadsheet for Select, Premium & UM Changes.
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
July 24, 2017 – Bristol-Myers Squibb announced the FDA approval of Yervoy (ipilimumab), for the treatment of unresectable or metastatic melanoma in adults and pediatric patients (12 years and older).
Return to publications